Abingworth LLP Exicure, Inc. Transaction History

Abingworth LLP

  • $301 Million
  • Q4 2022

A detailed history of Abingworth LLP transactions in Exicure, Inc. stock. As of the latest transaction made, Abingworth LLP holds 281,636 shares of XCUR stock, worth $5.18 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
281,636
Previous 281,636 -0.0%
Holding current value
$5.18 Million
Previous $439,000 26.42%
% of portfolio
0.11%
Previous 0.15%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022
BUY
$1.53 - $8.5 $430,903 - $2.39 Million
281,636 New
281,636 $439,000

Others Institutions Holding XCUR

# of Institutions
2
Shares Held
287K
Call Options Held
0
Put Options Held
0
View Full List

About EXICURE, INC.

XCUR Quotes by TradingView
  • Ticker XCUR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 4,962,580
  • Market Cap $91.2M
  • Description
  • Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie...
More about XCUR
Track This Portfolio

Track Abingworth LLP Portfolio

Follow Abingworth LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abingworth LLP, based on Form 13F filings with the SEC.

News

Stay updated on Abingworth LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email